healthcare professionals
close-image
hamburger-icon

Q4 presentation 18 feb 2021

Stock exchange news
Navamedic share
plus minus
Financial results
plus minus
Financial calendar
Corporate governance
12
Countries in which products are available
188.8mnok
Revenue 2019
Share price

More about the share
News from Navamedic
08.04.2021
Navamedic ASA: Enters long term distribution agreement for PrecisionBiotics Zenflore® in the Nordics with Novozymes.
“We are proud to announce the agreement with Novozymes which expands our product portfolio within probiotics for specific disease areas in the Nordics. The agreement Read more
Read more
18.02.2021
Navamedic ASA: Q4 2020 financial results
“The fourth quarter of 2020 displayed strong growth in our underlying portfolio and new products introduced during the second half of the year. Key growth Read more
Read more
Read more news
Financial calendar
Date
Event subject
18.02.2021
Quarterly Presentation – Q4
30.04.2021
Annual Report
11.05.2021
Quarterly Presentation – Q1
03.06.2021
Annual General Meeting
13.08.2021
Half-yearly report
Financial calendar
Subscribe to stock exchange news